62 related articles for article (PubMed ID: 38430249)
1. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma.
Pourhamzeh M; Asadian S; Mirzaei H; Minaei A; Shahriari E; Shpichka A; Es HA; Timashev P; Hassan M; Vosough M
Mol Cell Biochem; 2023 Jan; 478(1):23-37. PubMed ID: 35708866
[TBL] [Abstract][Full Text] [Related]
2. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
3. Mechanism exploration of Zoledronic acid combined with PD-1 in the treatment of hepatocellular carcinoma.
Fan X; Yan Z; Lin Y; Wang Q; Jiang L; Yao X; Dong L; Chen L; Zhao T; Zhao J; Hu H; Wang H
Cancer Immunol Immunother; 2024 Mar; 73(4):62. PubMed ID: 38430249
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
5. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
[TBL] [Abstract][Full Text] [Related]
7. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
8. PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model.
Li Y; Du Y; Sun T; Xue H; Jin Z; Tian J
BMC Cancer; 2018 Jun; 18(1):669. PubMed ID: 29921237
[TBL] [Abstract][Full Text] [Related]
9. Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma.
Zakeri N; Hall A; Swadling L; Pallett LJ; Schmidt NM; Diniz MO; Kucykowicz S; Amin OE; Gander A; Pinzani M; Davidson BR; Quaglia A; Maini MK
Nat Commun; 2022 Mar; 13(1):1372. PubMed ID: 35296658
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Polarization and Its Role in Liver Disease.
Wang C; Ma C; Gong L; Guo Y; Fu K; Zhang Y; Zhou H; Li Y
Front Immunol; 2021; 12():803037. PubMed ID: 34970275
[TBL] [Abstract][Full Text] [Related]
11. GOLM1 exacerbates CD8
Chen J; Lin Z; Liu L; Zhang R; Geng Y; Fan M; Zhu W; Lu M; Lu L; Jia H; Zhang J; Qin LX
Signal Transduct Target Ther; 2021 Nov; 6(1):397. PubMed ID: 34795203
[TBL] [Abstract][Full Text] [Related]
12. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.
Maeser D; Gruener RF; Huang RS
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34260682
[TBL] [Abstract][Full Text] [Related]
13. Macrophage Polarization States in the Tumor Microenvironment.
Boutilier AJ; Elsawa SF
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma.
Llovet JM; Kelley RK; Villanueva A; Singal AG; Pikarsky E; Roayaie S; Lencioni R; Koike K; Zucman-Rossi J; Finn RS
Nat Rev Dis Primers; 2021 Jan; 7(1):6. PubMed ID: 33479224
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-Based Approaches for Cancer Immunotherapy.
Anderson NR; Minutolo NG; Gill S; Klichinsky M
Cancer Res; 2021 Mar; 81(5):1201-1208. PubMed ID: 33203697
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
